The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome) | MicrobiomeTrials← Back to trialsNCT05237505
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-02-13Est. Completion: 2028-08-31
Enrollment target: 240 participants Locations- UCSD Sleep Research, La Jolla, California, United States
Other microbiome trials you might be interested in
Obstructive Sleep ApneaCognitive Decline
The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multi…
Tucson, United StatesEst. completion Aug 31, 2027
Sleep ApneaObstructive Sleep ApneaPulmonary HypertensionEpidemiologyPredictorPrognosisOutcomesMortality
The investigators propose a prospective, observational study to determine the impact of OSA and associated physiological…
Beijing, ChinaEst. completion Dec 31, 2028
OSA COPD Overlap Syndrome
This pilot study compares two positive airway pressure strategies for patients with both COPD and obstructive sleep apne…
Multiple LocationsEst. completion Nov 2028